Experience with OxyELITE Pro and Acute Liver Injury in Active Duty Service Members

Digestive Diseases and Sciences

Volumn 59, Issue 12, 2014, Pages 3117-3121

  Foley, Sean ^a   Butlin, Evan ^a   Shields, Wade ^a   Lacey, Brent ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

1,3 Dimethylamylamine; 1,3 DMAA; Active duty military; Case series; DILI; Drug induced liver injury; Liver failure; OxyELITE Pro; Sport supplements; Sports supplements

Indexed keywords

4 METHYL 2 HEXYLAMINE; ACETYLCYSTEINE; ALANINE AMINOTRANSFERASE; BILIRUBIN; CREATININE; 17-N,N-DIETHYLCARBAMOYL-4-METHYL-4-AZAANDROSTANE-3-ONE; ANDROSTANOLONE; AZASTEROID;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ABSTINENCE; ACUTE LIVER FAILURE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ATHLETE; AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; BLOOD CLOTTING DISORDER; BRAIN DISEASE; CLINICAL ARTICLE; CLINICAL STUDY; COMMON BILE DUCT STONE; CREATININE BLOOD LEVEL; DIET SUPPLEMENTATION; DISEASE DURATION; ENDOSCOPIC ECHOGRAPHY; EPSTEIN BARR VIRUS; EVALUATION STUDY; FATIGUE; FEMALE; FOLLOW UP; HEADACHE; HUMAN; HYPERBILIRUBINEMIA; INTERNATIONAL NORMALIZED RATIO; JAUNDICE; LETHARGY; LIVER DISEASE; LIVER DYSFUNCTION; LIVER FUNCTION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NAUSEA; POPULATION; PREVALENCE; STEATORRHEA; TACHYCARDIA; TOXIC HEPATITIS; UNITED STATES; VIRUS HEPATITIS; VOMITING; WILSON DISEASE; YOUNG ADULT; ANALOGS AND DERIVATIVES; CASE REPORT; DRUG-INDUCED LIVER INJURY; LIVER FAILURE, ACUTE; PATHOLOGY; SOLDIER;

ADULT; AZASTEROIDS; DIETARY SUPPLEMENTS; DIHYDROTESTOSTERONE; DRUG-INDUCED LIVER INJURY; FEMALE; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MILITARY PERSONNEL; YOUNG ADULT;

EID: 84912574295     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-014-3221-4     Document Type: Article

References (12)

1. Lee WM, Hynan LS, Rossaro L, Fontana RJ, Stravitz RT, Larson AM, Davern II TL, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009;137:856–64, 864.e1.
2. Reuben A, Koch DG, Lee WM. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology. 2010;52:2065–2076.
3. Gahche J, Bailey R, Burt V, Hughes J, Yetley E, Dwyer J, Picciano MF, et al. Dietary supplement use among U.S. adults has increased since NHANES III (1988–1994). NCHS Data Br. 2011;61:1–8.
4. Lieberman HR, Stavinoha TB, McGraw SM, White A, Hadden LS, Marriott BP. Use of dietary supplements among active-duty U.S. army soldiers. Am J Clin Nutr. 2010;92:985–995.
5. Sheppard HL, Raichada SM, Kouri KM, Stenson-Bar-Maor L, Branch JD. Use of creatine and other supplements by members of civilian and military health clubs: a cross-sectional survey. Int J Sport Nutr Exerc Metab. 2000;10:245–259.
6. Mcarthy CG, Canale RE, Alleman RJ Jr, Reed JP, Bloomer RJ. Biochemical and anthropometric effects of a weight loss dietary supplement in healthy men and women. Nutr Metab Insights. 2011;6:13–22.
7. Schilling BK, Hammond1 KG, Bloomer RJ, Presley CS, Yates CR. Physiological and pharmacokinetic effect of oral 1,3-dimethylamylamine administration in men. BMC Pharmacol Toxicol. 2013;4:52.
8. Market Research. Sports nutrition and weight loss report. 2011. http://www.marketresearch.com/Nutrition-Business-Journal-v2520/Sports-Nutrition-Weight-Loss-6382146/. Accessed 10 Apr 2014.
9. “Dimethylamylamine.” Natural Medicines Comprehensive Database (2013). http://naturaldatabase.therapeuticresearch.com/nd/Search.aspx?cs=CEPDA~DOD&s=ND&&pt=102&id=1258&name=DIMETHYLAMYLAMINE. Accessed March 3, 2014.
10. “DMAA in Dietary Supplements.” U.S. Food and Drug Administration. Press Release, July 16, 2013. http://www.fda.gov/food/dietarysupplements/qadietarysupplements/ucm346576.htm. Accessed March 3, 2014.
11. Park SY, Viray M, Johnston, D, Taylor E, Chang A, Martin C, Martin JG, et al. Notes from the field: acute hepatitis and liver failure following the use of a dietary supplement intended for weight Loss or muscle building—May–October 2013. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report (62(40):817–819); 2013. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6240a1.htm. Accessed 10 Apr 2014.
12. Canacio A, Eliason MJ, Mercer J, Tran T, Deuster PA, Stephens MB. Third-party certification of dietary supplements: prevalence and concerns. Mil Med. 2012;177:1460–1463.